BIO Applauds Bipartisan Senate Letter on U.S.-China Trade Negotiations

BIO President and CEO Jim Greenwood today applauded a letter authored by Senators Pat Roberts (R-Kan.) and Debbie Stabenow (D-Mich.) to President Trump urging him to continue prioritizing in U.S.-China trade negotiations the need for China to commit to systemic change and implement a predictable, timely, transparent, and science-based biotech crop approval process. 

BIO Applauds Trump Administration for Moving Closer to Fulfilling E15 Promise

The Biotechnology Innovation Organization (BIO) released the following statement after the U.S. Environmental Protection Agency (EPA) announced its proposed rule allowing for the summertime use of E15 gasoline.

BIO Urges Congress to Extend Biofuels Tax Incentives

The Biotechnology Innovation Organization BIO today submitted the following statement for the record to the House Ways and Means Subcommittee on Select Revenue Measures urging Congress to retroactively extend the biofuels tax incentives that expired at the end of 2017. The subcommittee today held a hearing entitled “Temporary Policy in the Internal Revenue Code.”

BIO Statement on President’s Proposed 2020 Budget

Washington, DC (March 11, 2019) – Biotechnology Innovation Organization (BIO) President and CEO Jim Greenwood issued the following statement today regarding President Trump’s FY 2020 budget proposal:

BIO Applauds FDA Action on AquAdvantage® Salmon

The Biotechnology Innovation Organization (BIO) released the following statement on the action taken today by the U.S. Food & Drug Administration (FDA) which will allow AquaBounty Technologies, an American company, to commercialize its genetically engineered AquAdvantage® Salmon in the U.S. market.

BIO Applauds Multi-Agency Framework for Advancing the Bioeconomy

The Biotechnology Innovation Organization (BIO) today released the following statement in response to the release of The Bioeconomy Initiative: Implementation Framework, a multi-agency strategy aimed at accelerating innovative technologies that harness the nation’s biomass resources for affordable biofuels, bioproducts, and biopower:

BIO Statement on Ambassador Lighthizer and Secretary Perdue Testimonies

BIO President and CEO Jim Greenwood released the following statement on U.S. Trade Representative Robert Lighthizer’s testimony at a House Ways and Means Committee hearing on the U.S.-China trade deal and U.S. Secretary of Agriculture Sonny Perdue’s testimony at a House Agriculture Committee hearing on the state of the rural economy.  

BIO Announces Partnership with Taiwan BIO for 2019 Conference and Exhibition

The Biotechnology Innovation Organization (BIO) announced today it will join the Taiwan Bio-Industry Organization (Taiwan BIO) to host BIO Asia-Taiwan from July 24-28 in Taipei, Taiwan. 

BIO Statement on CMS Proposed Decision Memo for the CAR-T National Coverage Determination

BIO Executive Vice President for Health Policy Dan Durham issued the following statement regarding the CMS proposed decision memo for the CAR-T National Coverage Determination.

Biomarkers: BIO Submits Comments on FDA Draft Guidance Biomarker Qualification: Evidentiary Framework

February 11, 2019